Medications for Stomach Neoplasms
45 results
Aminocaproic acid (aminocaproic acid)
(Aminocaproic Acid)VistaPharm, LLC
Usage: Aminocaproic acid is indicated for enhancing hemostasis in bleeding due to fibrinolysis, particularly in life-threatening situations. It is used in cases involving surgical complications, hematological disorders, abruptio placentae, hepatic cirrhosis, neoplastic diseases, and excessive urinary tract bleeding related to surgeries or conditions affecting the genitourinary system.
Aminocaproic acid (aminocaproic acid)
(Aminocaproic Acid)Seton Pharmaceuticals, LLC
Usage: Aminocaproic acid tablets enhance hemostasis in cases where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. It also addresses excessive urinary bleeding following surgical or nonsurgical procedures in the genitourinary system.
Aminocaproic acid (aminocaproic acid)
(AMINOCAPROIC ACID)Carnegie Pharmaceuticals, LLC
Usage: Aminocaproic acid enhances hemostasis in cases of fibrinolysis-related bleeding, particularly during heart surgery, in hematological disorders, and during severe conditions like abruptio placentae and certain cancers. It also addresses excessive urinary tract bleeding associated with surgical or nonsurgical hematuria.
Aminocaproic acid (aminocaproic acid)
(AMINOCAPROIC ACID)PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Usage: Aminocaproic acid is indicated for enhancing hemostasis in cases of bleeding due to fibrinolysis, especially following heart surgeries, in hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. It also addresses excessive urinary tract bleeding related to surgical or nonsurgical hematuria.
Aminocaproic acid (aminocaproic acid)
(Aminocaproic acid)airis PHARMA Private Limited
Usage: Aminocaproic acid oral solution is indicated for enhancing hemostasis in cases of fibrinolytic bleeding, particularly post-heart surgery, in hematological disorders, during acute abruptio placentae, in hepatic cirrhosis, and certain cancers. It can also address excessive urinary tract bleeding linked to surgical or nonsurgical hematuria.
Capecitabine (capecitabine)
(capecitabine)BluePoint Laboratories
Usage: Capecitabine is indicated for the treatment of various cancers, including Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, and unresectable or metastatic gastric and pancreatic cancers, often in combination with other chemotherapy agents.
Capecitabine (capecitabine)
(Capecitabine)Aurobindo Pharma Limited
Usage: Capecitabine tablets are indicated for the treatment of Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, unresectable gastric or esophageal cancers, and as adjuvant therapy for pancreatic adenocarcinoma in combination with chemotherapy regimens.
Conray (iothalamate meglumine)
(iothalamate meglumine)Liebel-Flarsheim Company LLC
Usage: Conray is indicated for excretory urography, angiography (cerebral, peripheral, venous), and various imaging techniques like computed tomography (CT) for detecting lesions in organs such as the liver and kidneys. It enhances diagnostic accuracy and visualization of lesions compared to unenhanced CT scans.
Cyclophosphamide (cyclophosphamide)
(cyclophosphamide)NextSource Pharma
Usage: Cyclophosphamide Capsules are indicated for treating various malignant diseases, including malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids.
Cyramza (ramucirumab)
(ramucirumab)Eli Lilly and Company
Usage: CYRAMZA is indicated for treating adults with advanced or metastatic gastric cancer, non-small cell lung cancer (NSCLC), colorectal cancer, and hepatocellular carcinoma. It is used alone or in combination with specific chemotherapy agents, depending on disease progression and specific tumor characteristics.